Ondine Biomedical (LON:OBI) Shares Up 4.2% - Here's What Happened

Key Points

• Ondine Biomedical shares jumped 4.2% mid-day to C$12.50, trading as high as C$13.00 on volume of 618,560 shares—about a 65% increase versus its average session volume.
• Ondine develops photodisinfection therapies to prevent and treat infections, with the platform used in over 100,000 patient treatments across hospitals, clinics and industrial settings in Canada.
• The company has a market cap of C$6.49 billion, a negative PE (-1.79), a high debt-to-equity ratio (76.45), a strong quick ratio (8.26) but a below-1 current ratio (0.97), and it trades above both its 50- and 200-day moving averages.

Ondine Biomedical Inc. (LON:OBI - ) shot up 4.2% during mid-day trading on Thursday . The company traded as high as C$13.00 and last traded at C$12.50. 618,560 shares changed hands during trading, an increase of 65% from the average session volume of 373,822 shares. The stock had previously closed at C$12.00.

Ondine Biomedical Stock Performance

The business's fifty day moving average price is C$10.68 and its 200-day moving average price is C$10.58. The company has a debt-to-equity ratio of 76.45, a quick ratio of 8.26 and a current ratio of 0.97. The stock has a market cap of C$6.49 billion, a PE ratio of -1.79 and a beta of 0.22.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.